{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:24:08Z","timestamp":1794507848769,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12886-019-1103-4","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T16:05:52Z","timestamp":1556813152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A case of cancer-associated retinopathy with chorioretinitis and optic neuritis associated with occult small cell lung cancer"],"prefix":"10.1186","volume":"19","author":[{"given":"William","family":"Carrera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy A.","family":"Tsamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,2]]},"reference":[{"key":"1103_CR1","volume-title":"Cancer Facts & Figures 2017","author":"American Cancer Society","year":"2017","unstructured":"American Cancer Society. Cancer Facts & Figures 2017. Atlanta: American Cancer Society; 2017."},{"issue":"34","key":"1103_CR2","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1200\/JCO.2015.63.7918","volume":"33","author":"C Rudin","year":"2015","unstructured":"Rudin C, Ismaila N, Hann CL, Malhotra N, Movsas B, Norris K, Pietanza MC, Ramalingam SS, Turrisi AT 3rd, Giaccone G. Treatment of small-cell lung Cancer: American Society of Clinical Oncology endorsement of the American College of Chest Physicians Guideline. J Clin Oncol. 2015;33(34):4106\u201311.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1103_CR3","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/cncr.29098","volume":"121","author":"LA Byers","year":"2015","unstructured":"Byers LA, Rudin CM. Small cell lung Cancer: where do we go from Here? Cancer. 2015;121(5):664\u201372.","journal-title":"Cancer."},{"issue":"5","key":"1103_CR4","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.autrev.2009.01.002","volume":"8","author":"G Adamus","year":"2009","unstructured":"Adamus G. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmun Rev. 2009;8(5):410\u20134.","journal-title":"Autoimmun Rev"},{"issue":"5","key":"1103_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/0002-9394(76)90125-2","volume":"81","author":"RA Sawyer","year":"1976","unstructured":"Sawyer RA, Selhorst JB, Zimmerman LE, Hoyt WF. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol. 1976;81(5):606\u201313.","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"1103_CR6","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/1097-0142(19821001)50:7<1289::AID-CNCR2820500711>3.0.CO;2-9","volume":"50","author":"SE Kornguth","year":"1982","unstructured":"Kornguth SE, Klein R, Appen R, Choate J. Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer. 1982;50(7):1289\u201393.","journal-title":"Cancer."},{"issue":"7","key":"1103_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/archopht.1993.01090070049018","volume":"111","author":"CE Thirkill","year":"1993","unstructured":"Thirkill CE, Keltner JL, Tyler NK. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy. Arch Ophthalmol. 1993;111(7):931\u20137.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"1103_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0002-9394(14)71979-8","volume":"122","author":"T Suzuki","year":"1996","unstructured":"Suzuki T, Obara Y, Sato Y, Saito G, Ichiwata T, Uchiyama T. Cancer-associated retinopathy with presumed vasculitis. Am J Ophthalmol. 1996;122(1):125\u20137.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"1103_CR9","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/00006982-199919050-00022","volume":"19","author":"N Masaoka","year":"1999","unstructured":"Masaoka N, Emoto Y, Sasaoka A, Fukushima A, Ueno H, Ohguro H. Fluorescein angiographic findings in a case of cancer-associated retinopathy. Retina. 1999;19(5):462\u20134.","journal-title":"Retina."},{"issue":"3","key":"1103_CR10","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.lungcan.2007.02.015","volume":"57","author":"M Kobayashi","year":"2007","unstructured":"Kobayashi M, Ikezoe T, Uemura Y, Ueno H, Taguchi H. Long-term survival of a patient with small cell lung cancer associated with cancer-associated retinopathy. Lung Cancer. 2007;57(3):399\u2013403.","journal-title":"Lung Cancer"},{"issue":"5","key":"1103_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019911","volume":"6","author":"M Kondo","year":"2011","unstructured":"Kondo M, Sanuki R, Ueno S, Nishizawa Y, Hashimoto N, Ohguro H, Yamamoto S, Machida S, Terasaki H, Adamus G, Furukawa T. Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction. PLoS One. 2011;6(5):e19911.","journal-title":"PLoS One"},{"key":"1103_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2415-14-5","volume":"14","author":"M Saito","year":"2014","unstructured":"Saito M, Saito W, Kanda A, Ohguro H, Ishida S. A case of paraneoplastic optic neuropathy and outer retinitis positive for autoantibodies against collapsing response mediator protein-5, recoverin and \u03b1-enolase. BMC Ophthalmol. 2014;14:5.","journal-title":"BMC Ophthalmol"},{"issue":"12","key":"1103_CR13","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/bjo.77.12.795","volume":"77","author":"Y Ohnishi","year":"1993","unstructured":"Ohnishi Y, Ohara S, Sakamoto T, Kohno T, Nakao F. Cancer-associated retinopathy with retinal phlebitis. Br J Ophthalmol. 1993;77(12):795\u20138.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"1103_CR14","first-page":"2768","volume":"33","author":"CE Thirkill","year":"1992","unstructured":"Thirkill CE, Tait RC, Tyler NK, Roth AM, Keltner JL. The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci. 1992;33(10):2768\u201372.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"1103_CR15","first-page":"2626","volume":"34","author":"G Adamus","year":"1993","unstructured":"Adamus G, Guy J, Schmied JL, Arendt A, Hargrave PA. Role of anti-recoverin autoantibodies in cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 1993;34(9):2626\u201333.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1103_CR16","first-page":"705","volume":"42","author":"T Maeda","year":"2001","unstructured":"Maeda T, Maeda A, Maruyama I, Ogawa KI, Kuroki Y, Sahara H, Sato N, Ohguro H. Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 2001;42(3):705\u201312.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1103_CR17","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1001\/archopht.1987.01060030092033","volume":"105","author":"CE Thirkill","year":"1987","unstructured":"Thirkill CE, Roth AM, Keltner JL. Cancer-associated retinopathy. Arch Ophthalmol. 1987;105(3):372\u20135.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"1103_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10633-014-9456-8","volume":"129","author":"S Machida","year":"2014","unstructured":"Machida S, Ohguro H, Ishida K, Suzuki M, Kawagishi K. Recoverin-associated retinopathy secondary to Warthin tumor of parotid gland. Doc Ophthalmol. 2014;129(2):123\u20138.","journal-title":"Doc Ophthalmol"},{"issue":"7","key":"1103_CR19","first-page":"1914","volume":"60","author":"A Maeda","year":"2000","unstructured":"Maeda A, Ohguro H, Maeda T, Wada I, Sato N, Kuroki Y, Nakagawa T. Aberrant expression of photoreceptor-specific calcium-binding protein (recoverin) in cancer cell lines. Cancer Res. 2000;60(7):1914\u201320.","journal-title":"Cancer Res"},{"key":"1103_CR20","first-page":"885","volume":"12","author":"A Maeda","year":"2006","unstructured":"Maeda A, Maeda T, Liang Y, Yenerel M, Saperstein DA. Effects of cytotoxic T lymphocyte antigen 4 (CTLA4) signaling and locally applied steroid on retinal dysfunction by recoverin, cancer-associated retinopathy antigen. Mol Vis. 2006;12:885\u201391.","journal-title":"Mol Vis"},{"issue":"2","key":"1103_CR21","first-page":"283","volume":"38","author":"G Adamus","year":"1997","unstructured":"Adamus G, Machnicki M, Seigel GM. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 1997;38(2):283\u201391.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"1103_CR22","first-page":"2589","volume":"42","author":"H Ohguro","year":"2001","unstructured":"Ohguro H, Ogawa K, Maeda T, Maruyama I, Maeda A, Takano Y, Nakazawa M. Retinal dysfunction in cancer-associated retinopathy is improved by ca(+2) antagonist administration and dark adaptation. Invest Ophthalmol Vis Sci. 2001;42(11):2589\u201395.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1103_CR23","doi-asserted-by":"crossref","unstructured":"Rizzo JF 3rd, Gittinger JW Jr. Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome. Ophthalmology 1992;99(8):1286\u20131295.","DOI":"10.1016\/S0161-6420(92)31806-8"},{"issue":"1","key":"1103_CR24","first-page":"46","volume":"32","author":"MC Boucher","year":"1997","unstructured":"Boucher MC, Allaire GS. Cancer-associated retinopathy: a clinicopathological case report. Can J Ophthalmol. 1997;32(1):46\u20139.","journal-title":"Can J Ophthalmol"},{"issue":"4","key":"1103_CR25","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/1097-0142(19870815)60:4<780::AID-CNCR2820600413>3.0.CO;2-9","volume":"60","author":"GB Grunwald","year":"1987","unstructured":"Grunwald GB, Kornguth SE, Towfighi J, Sassani J, Simmonds MA, Housman CM, Papadopoulos N. Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Retinal immune deposits and ablation of retinal ganglion cells. Cancer. 1987;60(4):780\u20136.","journal-title":"Cancer."},{"issue":"10","key":"1103_CR26","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.4161\/cc.9.10.11521","volume":"9","author":"R Cao","year":"2010","unstructured":"Cao R, Cao Y. Cancer-associated retinopathy: a new mechanistic insight on vascular remodeling. Cell Cycle. 2010;9(10):1882\u20135.","journal-title":"Cell Cycle"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-019-1103-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-019-1103-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-019-1103-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T23:18:24Z","timestamp":1588288704000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-019-1103-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1103"],"URL":"https:\/\/doi.org\/10.1186\/s12886-019-1103-4","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,2]]},"assertion":[{"value":"26 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Per institutional guidelines, Institutional Review Board approval was not required for the preparation of this manuscript. CARE guidelines were adhered to in the preparation of this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient described in this report provided written, informed consent for the publication of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"101"}}